WO1998033896A3 - Microorganisms with increased production of clavulanic acid - Google Patents

Microorganisms with increased production of clavulanic acid Download PDF

Info

Publication number
WO1998033896A3
WO1998033896A3 PCT/EP1998/000644 EP9800644W WO9833896A3 WO 1998033896 A3 WO1998033896 A3 WO 1998033896A3 EP 9800644 W EP9800644 W EP 9800644W WO 9833896 A3 WO9833896 A3 WO 9833896A3
Authority
WO
WIPO (PCT)
Prior art keywords
microorganisms
clavulanic acid
increased production
clavulanic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/000644
Other languages
French (fr)
Other versions
WO1998033896A2 (en
Inventor
Barry Barton
John Patrick Griffin
Roy Henry Mosher
Ashish Sudhakar Paradkar
Susan Jensen
Cecilia Anders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
SmithKline Beecham Ltd
Original Assignee
University of Alberta
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SK1054-99A priority Critical patent/SK105499A3/en
Priority to KR10-1999-7006973A priority patent/KR100514964B1/en
Priority to EP98906924A priority patent/EP0970198B1/en
Priority to CA002279207A priority patent/CA2279207A1/en
Priority to PL98334961A priority patent/PL334961A1/en
Priority to JP53256398A priority patent/JP4227199B2/en
Priority to AU62953/98A priority patent/AU735782B2/en
Priority to DE69832783T priority patent/DE69832783T2/en
Priority to EA199900718A priority patent/EA003773B1/en
Priority to AT98906924T priority patent/ATE312926T1/en
Priority to IL13104398A priority patent/IL131043A0/en
Application filed by University of Alberta, SmithKline Beecham Ltd filed Critical University of Alberta
Priority to APAP/P/1999/001614A priority patent/AP1320A/en
Priority to BR9807144-0A priority patent/BR9807144A/en
Priority to NZ336894A priority patent/NZ336894A/en
Publication of WO1998033896A2 publication Critical patent/WO1998033896A2/en
Publication of WO1998033896A3 publication Critical patent/WO1998033896A3/en
Priority to NO993758A priority patent/NO993758D0/en
Anticipated expiration legal-status Critical
Priority to BG103704A priority patent/BG103704A/en
Priority to US10/214,519 priority patent/US20030166175A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, e.g. clavulanic acid.
PCT/EP1998/000644 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid Ceased WO1998033896A2 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IL13104398A IL131043A0 (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid
EP98906924A EP0970198B1 (en) 1997-02-04 1998-02-02 Micro-organisms with increased production of clavulanic acid
CA002279207A CA2279207A1 (en) 1997-02-04 1998-02-02 Novel compounds
PL98334961A PL334961A1 (en) 1997-02-04 1998-02-02 Micro-organisms of increased clavulanic acid production
JP53256398A JP4227199B2 (en) 1997-02-04 1998-02-02 Microorganisms that produce large amounts of clavulanic acid
AU62953/98A AU735782B2 (en) 1997-02-04 1998-02-02 Novel compounds
DE69832783T DE69832783T2 (en) 1997-02-04 1998-02-02 MICROORGANISMS WITH INCREASED PREPARATION OF CLAVLANIC ACID
EA199900718A EA003773B1 (en) 1997-02-04 1998-02-02 Dna sequences for 5s clavam biosynthesis in streptomyces clavuligerus microorganisms, streptomyces clavuligerus microorganism strains, containing said dna sequences and a process for improving 5r clavam production, in particular, clavulanic acid in streptomyces clavuligerus microorganisms
APAP/P/1999/001614A AP1320A (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid.
SK1054-99A SK105499A3 (en) 1997-02-04 1998-02-02 Dna comprising one or more genes specific for biosythesis of 5s clavam in s. clavuligerus, a vector containing dna, a host containing such vectors, process for improving the manufacture of 5r clavam and method for identification of microorganisms
KR10-1999-7006973A KR100514964B1 (en) 1997-02-04 1998-02-02 Microorganisms with Increased Production of Clavulanic Acid
AT98906924T ATE312926T1 (en) 1997-02-04 1998-02-02 MICROORGANISMS WITH INCREASED PRODUCTION OF CLAVULANIC ACID
BR9807144-0A BR9807144A (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid
NZ336894A NZ336894A (en) 1997-02-04 1998-02-02 Bacterial genes specific for biosynthesis of 5S clavams, and manipulation of these genes to produce raised levels of clavulanic acid
NO993758A NO993758D0 (en) 1997-02-04 1999-08-03 New compounds and microorganisms with increased production of clavulanic acid
BG103704A BG103704A (en) 1997-02-04 1999-09-01 New compounds
US10/214,519 US20030166175A1 (en) 1997-02-04 2002-11-07 Process for clavulanic acid production

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product
GB9702218.0 1997-02-04

Publications (2)

Publication Number Publication Date
WO1998033896A2 WO1998033896A2 (en) 1998-08-06
WO1998033896A3 true WO1998033896A3 (en) 1998-11-19

Family

ID=10807030

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/000644 Ceased WO1998033896A2 (en) 1997-02-04 1998-02-02 Microorganisms with increased production of clavulanic acid

Country Status (32)

Country Link
US (5) US6936458B1 (en)
EP (2) EP0970198B1 (en)
JP (2) JP4227199B2 (en)
KR (2) KR100514964B1 (en)
CN (2) CN1192107C (en)
AP (1) AP1320A (en)
AR (2) AR011100A1 (en)
AT (1) ATE312926T1 (en)
AU (1) AU735782B2 (en)
BG (1) BG103704A (en)
BR (1) BR9807144A (en)
CA (1) CA2279207A1 (en)
DE (1) DE69832783T2 (en)
DZ (1) DZ2413A1 (en)
EA (1) EA003773B1 (en)
ES (1) ES2255149T3 (en)
GB (1) GB9702218D0 (en)
HU (1) HUP0001048A3 (en)
ID (1) ID22144A (en)
IL (1) IL131043A0 (en)
MA (1) MA24464A1 (en)
MY (1) MY140928A (en)
NO (1) NO993758D0 (en)
NZ (1) NZ336894A (en)
OA (1) OA11082A (en)
PL (1) PL334961A1 (en)
SK (1) SK105499A3 (en)
TR (1) TR199901862T2 (en)
TW (2) TW589377B (en)
UY (2) UY24874A1 (en)
WO (1) WO1998033896A2 (en)
ZA (1) ZA98868B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7983400A (en) * 1999-09-16 2001-04-17 Johns Hopkins University, The Improvement of clavulanic acid production
JP2003512832A (en) * 1999-10-22 2003-04-08 スミスクライン ビーチャム パブリック リミテッド カンパニー 5R clabham-producing microorganism lacking LAT and CVM genes
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (en) * 2018-01-04 2020-12-08 上海交通大学 Streptomyces marine DUT11 and its application in anti-complement activity
CN114072493A (en) 2019-07-05 2022-02-18 葛兰素史密斯克莱知识产权（第2 号）有限公司 Streptomyces clavuligerus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2108113A1 (en) * 1993-10-08 1995-04-09 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
SE421796B (en) * 1975-02-07 1982-02-01 Glaxo Lab Ltd PROCEDURE FOR PURIFICATION OF CLAVULANIC ACID AND ITS SALTS
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (en) 1977-02-24 1983-02-22 武田薬品工業株式会社 Antibiotic manufacturing method
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2108113A1 (en) * 1993-10-08 1995-04-09 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A.S. PARADKAR AND S.E. JENSEN: "Functional analysis of the gene encoding the clavaminate synthase 2 isoenzyme involved in clavulanic acid biosynthesis in Streptomyces clavuligerus", JOURNAL OF BACTERIOLOGY, vol. 177, no. 5, 1995, WASHINGTON, DC, US, pages 1307 - 1314, XP002072687 *
E.N. MARSCH ET AL.,: "Two isozymes of clavaminate synthase central to clavulanic acid formation: cloning and sequencing of both genes from Streptomyces clavuligerus", BIOCHEMISTRY, vol. 31, 1992, WASHINGTON, DC, US, pages 12648 - 12657, XP002072686 *
J.E. HODGSON ET AL.,: "Clavulanic acid biosynthesis in Streptomyces clavuligerus: gene cloning and characterization", GENE, vol. 166, 1995, AMSTERDAM, NL, pages 49 - 55, XP002072689 *
J.M. WARD AND J.E. HODGSON: "The biosynthetic genes for clavulanic acid and cephamycin production occur as a 'super-cluster' in three Streptomyces", FEMS MICROBIOLOGICAL LETTERS, vol. 110, 1993, AMSTERDAM, NL, pages 239 - 242, XP000601357 *
K.A. AIDOO ET AL.,: "Cloning, sequencing and disruption of a gene from Streptomyces clavuligerus involved in clavulanic acid biosynthesis", GENE, vol. 147, 1994, AMSTERDAM, NL, pages 41 - 46, XP002072688 *

Also Published As

Publication number Publication date
US20030124690A1 (en) 2003-07-03
NZ336894A (en) 2001-08-31
AR011100A1 (en) 2000-08-02
US20070298470A1 (en) 2007-12-27
TR199901862T2 (en) 2000-12-21
BG103704A (en) 2000-05-31
EP1405913A2 (en) 2004-04-07
DZ2413A1 (en) 2003-01-04
TW200307041A (en) 2003-12-01
EA199900718A1 (en) 2000-02-28
EP0970198A2 (en) 2000-01-12
DE69832783T2 (en) 2006-07-20
JP5042186B2 (en) 2012-10-03
KR20050053794A (en) 2005-06-08
AU6295398A (en) 1998-08-25
CN1696301A (en) 2005-11-16
MA24464A1 (en) 1998-10-01
UY25197A1 (en) 1998-11-27
KR20000070723A (en) 2000-11-25
AU735782B2 (en) 2001-07-12
JP2009022298A (en) 2009-02-05
ES2255149T3 (en) 2006-06-16
GB9702218D0 (en) 1997-03-26
EP1405913A3 (en) 2004-08-04
ZA98868B (en) 1999-08-03
EA003773B1 (en) 2003-08-28
IL131043A0 (en) 2001-01-28
EP0970198B1 (en) 2005-12-14
CN1251612A (en) 2000-04-26
MY140928A (en) 2010-02-12
US20030166175A1 (en) 2003-09-04
HUP0001048A2 (en) 2000-08-28
CA2279207A1 (en) 1998-08-06
HUP0001048A3 (en) 2001-09-28
US6936458B1 (en) 2005-08-30
PL334961A1 (en) 2000-03-27
AR018304A2 (en) 2001-11-14
ID22144A (en) 1999-09-09
BR9807144A (en) 2000-01-25
US20030022321A1 (en) 2003-01-30
DE69832783D1 (en) 2006-01-19
SK105499A3 (en) 2000-05-16
ATE312926T1 (en) 2005-12-15
CN1192107C (en) 2005-03-09
NO993758L (en) 1999-08-03
NO993758D0 (en) 1999-08-03
OA11082A (en) 2003-03-13
AP1320A (en) 2004-10-29
JP4227199B2 (en) 2009-02-18
UY24874A1 (en) 2001-07-31
WO1998033896A2 (en) 1998-08-06
US7344869B2 (en) 2008-03-18
KR100514964B1 (en) 2005-09-15
AP9901614A0 (en) 1999-09-30
TW589377B (en) 2004-06-01
JP2001511001A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
AU7839594A (en) Strategy for the production of rna from immobilized templates
WO2002018617A3 (en) Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria
AU2294788A (en) Apparatus for the intensive, controlled production of microorganisms by photosynthesis
WO1999057325A3 (en) Enzymes mixture
AU7375794A (en) Process for isolating nucleic acid from gram positive microorganisms
AU6577996A (en) Fermented formula feed, its production, and uses
AU6452094A (en) Ubiquitin carrier enzyme E2-F1 purification, production, and use
WO2001018195A3 (en) Luciferase expression cassettes and methods of use
AU604806B2 (en) Antibiotic a10255 complex and factors, microorganisms, process and production therefor
AU2777097A (en) Process and carrier for the production of isomaltulose by immobilized micro-organisms
AU2912297A (en) Antibiotic producing microbe
WO1998033896A3 (en) Microorganisms with increased production of clavulanic acid
EP1106679A4 (en) Process for producing fermentation product
AU4912799A (en) Process for the production of mannitol by immobilized micro-organisms
AU9264598A (en) Statin production by fermentation
AU1192797A (en) Oxidase, microorganisms producing the same and use of the same
WO1998046768A3 (en) Phenolic acid esterase and use thereof
AU1446192A (en) Process for the production of antibiotics, dna-sequences, recombinant-dna-constructs and microbial strains used therein
AU4695700A (en) Bacterial strains and fermentation processes for the production of 2-keto-l-gulonic acid
AU4732396A (en) Novel lipase, process for producing the same, and microorganism producing the same
AU2002336564A1 (en) Method of enzyme production by microorganisms
WO2001030977A3 (en) 5r clavam producing microorganisms with deleted lat and cvm genes
EP0342341A3 (en) Process for producing antitumor antibiotic ll-e33288gamma2
GB9424950D0 (en) Novel process
WO2004092389A3 (en) New process for improving the manufacture of clavams e.g. clavulanic acid

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 131043

Country of ref document: IL

Ref document number: 98803747.5

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT GH

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 62953/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 336894

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2279207

Country of ref document: CA

Ref document number: 2279207

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 105499

Country of ref document: SK

Ref document number: 1998906924

Country of ref document: EP

Ref document number: 1019997006973

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 1998 532563

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/007257

Country of ref document: MX

Ref document number: PV1999-2775

Country of ref document: CZ

Ref document number: 1999/01862

Country of ref document: TR

Ref document number: 1199900628

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 199900718

Country of ref document: EA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998906924

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1999-2775

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019997006973

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 62953/98

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1019997006973

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1998906924

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1999-2775

Country of ref document: CZ